Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two-period, Multicenter, Randomized, Open-label, Phase II Study Evaluating the Clinical Benefit of a Maintenance Treatment Targeting Tumor Molecular Alterations in Patients With Progressive Locally-advanced or Metastatic Solid Tumors

NCT02029001 is registered in ClinicalTrials.gov with Centre Leon Berard as lead sponsor.

NCT NCT02029001
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02029001 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two-period, Multicenter, Randomized, Open-label, Phase II Study Evaluating the Clinical Benefit of a Maintenance Treatment Targeting Tumor Molecular Alterations in Patients With Progressive Locally-advanced or Metastatic Solid Tumors
Lead sponsor
Centre Leon Berard
Phase
Phase 2
Overall status
Recruiting
Start date
March 31, 2014
Completion date
October 31, 2028
Enrollment
900 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

malignant solid neoplasms